ACADIA Pharmaceuticals Inc
SWB:DR6
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
ACADIA Pharmaceuticals Inc
SWB:DR6
|
US |
|
H
|
Haldyn Glass Ltd
BSE:515147
|
IN |
|
B
|
Banco Santander SA
VSE:SAN
|
ES |
|
W
|
Western Energy Services Corp
OTC:WEEEF
|
CA |
|
A
|
Aecon Group Inc
XMUN:2AE
|
CA |
|
Tokai Carbon Co Ltd
OTC:TKCBF
|
JP |
|
L
|
Lloyds Banking Group PLC
DUS:LLD
|
UK |
|
OCI NV
AEX:OCI
|
NL |
|
W
|
Weatherford International PLC
F:0WE
|
US |
Intrinsic Value
Is DR6 undervalued or overvalued?
See the intrinsic value estimate for 
ACADIA Pharmaceuticals Inc and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
DR6 looks undervalued.
But is it cheap by its own standards?
See how today’s valuation compares with DR6’s past valuations and how the stock performed after similar periods.
Fundamental Analysis
What ACADIA Pharmaceuticals Does
ACADIA Pharmaceuticals is a biopharmaceutical company that develops and sells prescription medicines for brain and nervous system disorders. Its main products are used by specialists and caregivers treating conditions that are hard to address with older drugs, especially diseases with limited treatment options.
- Headquarters
- United States of America US
- Employees
- 797
- IPO date
- May 27, 2004
Revenue & Expenses Breakdown
ACADIA Pharmaceuticals Inc
Earnings Waterfall
ACADIA Pharmaceuticals Inc
The intrinsic value for ACADIA Pharmaceuticals Inc (DR6) under the Base Case is hidden EUR.
Compared with the current market price of 23.37 EUR, the stock appears hidden.